Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Improved Outcomes after Lower Limb Revascularization

Operator ability combined with improved and diverse devices for lower limb revascularization has clearly increased in the last decade. However, is this technical feasibility we did not use to have translating into better clinical outcomes for patients, or is it simply inflating our interventionist egos?

Mejorando los resultados luego de la revascularización de miembros inferiores

This study aims at answering the question above by identifying an astonishing 103934 patient population undergoing endovascular (endarterectomy) or surgical (profundaplasty or bypass) lower limb revascularization for infrainguinal peripheral artery disease between 2006 and 2015.

Major amputation and deaths within a year after procedure were registered and adjusted by age, sex, diabetes and other comorbidities, in addition to revascularization indication (Intermittent claudication, severe ischemia with tissue loss, severe ischemia with gangrene/osteomyelitis).

The risk of major amputation at one year after endovascular procedure dropped from 5.7% (2006-2007) to 3.9% (2014-2015). For surgical revascularization, risk dropped from 11.2% (2006-2007) to 6.6% (2014-2015).


Read also: Peri-Procedural Infarction in Angioplasty vs. Surgery in the Left Main Coronary Artery.


Mortality risk after both revisualization types also dropped over time. These trends were observed in all the clinical spectrum that justified revascularization indication, though the biggest benefit was in patients with severe ischemia and tissue loss or gangrene.

A curiosity observed over the years is increased morbidity, which could easily be explained by a larger proportion of patients treated at the end of their disease (sever ischemia with tissue los or gangrene) by less invasive methods.

Conclusion

These ten-year findings show an increase of survival rate and a reduction in major amputation after revascularization procedures. Outcomes have effectively improved hand in hand with experience and new devices, which justifies centralization and specialization of peripheral vascular centers.

Original Title: Improving 1-year Outcomes of Infrainguinal Limb Revascularisation: A Population-Based Cohort Study of 104 000 Patients in England.

Reference: Heikkila et al. Circulation. 2018 May 1;137(18):1921-1933.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Su opinión nos interesa. Puede dejar su comentario, reflexión, pregunta o lo que desee aquí abajo. Será más que bienvenido.

More articles by this author

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

C-TRACT: Endovascular therapy in post-thrombotic syndrome due to iliac obstruction

Post-thrombotic syndrome (PTS) is one of the most limiting sequelae following proximal deep vein thrombosis (DVT). It clinically manifests as chronic pain, edema, skin...

Coil embolization of segmental arteries as a spinal cord protection strategy prior to complex endovascular repair of thoracoabdominal aorta

Spinal cord ischemia remains one of the most devastating complications in the repair of thoracoabdominal aneurysms, with incidences of up to 20–30% in extensive...

Mechanical thrombectomy versus anticoagulation in intermediate-risk pulmonary embolism: systematic review and meta-analysis

Intermediate-risk pulmonary embolism (PE) has anticoagulation as the standard treatment, while reperfusion strategies remain a matter of debate. In this context, mechanical thrombectomy has...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...